A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev

NCT04649489 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

501

Enrollment

OTHER

Sponsor class

Conditions

Venous Thrombosis

Interventions

DRUG: Atezolizumab & Bevacizumab
PROCEDURE: Surgery followed by atezolizumab and bevacizumab

Sponsor

Jia Fan